PACB — analysis and forecast
🧬 Faro multibagger DNA
Does it look today like the big multibaggers (×10, ×100) did when they started? 7 traits measured with public data.
Strongest: Room to grow and Cash it generates. Most lacking: Balance sheet and Business quality.
Worth $623 M. To grow ×10 it would have to reach $6.2 B.
Sales +6% last quarter (year over year) and +4% last fiscal year.
Gross margin 28%, operating margin -333%, return on equity —.
Free cash flow $44 M a year = 7.1% of its value.
Trades at 3.9× sales: 0.82 per point of growth (lower is better).
Net debt equal to 82% of its value.
No recent federal contracts on the radar · inside a Faro megatrend · insiders own 8.8%.
⏱️ Timing (not scored): mid-range over 12 months (39%) · above its 200-day average · beating the S&P 500 by 15 points over 12 months.
Built on the traits of 365 stocks that went ×100 (Mayer, 1962–2014) and 464 that went ×10 (Yartseva, 2009–2024), plus the Faro thesis. It does not predict the price and is not a recommendation. How it works and the ranking →
🔢 What the numbers say
The last 12 months, in plain words
- Over the last year PACB is up 7.3%. Over about two years: -9.7%.
- Today it sits 31.2% below its 52-week high ($2.90) and +79.7% above the low ($1.11).
- The worst drop from a peak in those 12 months was 58.4%. Anyone who bought at the top had to sit through that.
- It rose on 45% of days. Best day: +29.5%. Worst day: -15.4%.
- Annual volatility around 106%: in a normal year a ±106% move would not be unusual for this stock (the S&P 500 usually runs 15–20%).
🗓️ Forecast by horizon
Directional bias · probability of rising · expected price and likely range (68%)
| Horizon | Bias | Prob. up | Expected price | 68% range |
|---|---|---|---|---|
| 1 day | Neutral | 51% | $1.99 -0.0% | $1.87 – $2.13 |
| 3 days | Neutral | 51% | $1.99 -0.1% | $1.78 – $2.24 |
| 1 week | Neutral | 51% | $1.99 -0.1% | $1.72 – $2.31 |
| 15 days | Bullish | 51% | $1.99 -0.2% | $1.61 – $2.46 |
| 1 month | Bullish | 51% | $1.99 -0.4% | $1.46 – $2.69 |
| 3 months | Bullish | 49% | $1.97 -1.3% | $1.16 – $3.34 |
Recent momentum: +1.8% over 20 days · +57.1% over 60 days. The further out the horizon, the wider and more uncertain the forecast.
📈 Probability cone
📜 Government contracts
We have no notable federal contract on file for PACB. You can look it up yourself at USASpending.gov or in the Government Sources hub.
📚 Go deeper: Faro Library reports
PDF reports built from official filings. Your first one is free, no email; then $1.99 each or all 34 for $25 — included in Navigator and Admiral.
The market's memory: 100 years of crashes and recoveriesSince 1927 the S&P 500 has fallen more than 20% about a dozen times. It always recovered, but sometimes it took 25 y…6 pp. · Free preview →
Study: What the big winners had in commonMicron 13x, Carpenter 12x, NVIDIA 9x… We analyze the stocks that rose most in five years within the Faro universe: which…6 pp. · Free preview →
Practical guide: How to read an earnings report in 15 minutesEvery three months companies publish their numbers. The market reacts in seconds. A 7-step method, with real 2026 exampl…6 pp. · Free preview →❓ Frequently asked questions about PACB
Could PACB be the next NVIDIA?
Its Faro multibagger DNA is 51/100 (mixed): it measures how much it looks today like the big multibaggers did when they started (size, sales growth, quality, cash, price versus growth, balance sheet and public contracts). To grow ×10 it would need to be worth about 10 times today's value. Not a prediction or a recommendation.
How much has PACB gone up in the last year?
Pacific Biosciences of California (PACB) is up 7.3% over the last 12 months and trades at $2.00, 31.2% below its 52-week high ($2.90). 52-week range: $1.11 – $2.90.
How volatile is PACB stock?
Its annualized volatility is around 106% and its worst drop from a peak over the last year was 58.4%. For reference, the S&P 500 usually moves 15–20% a year.
Does PACB have U.S. government contracts?
There is no notable federal contract in Faro's register. You can search USASpending.gov.
Is now a good time to buy PACB?
Nobody can know that for sure and this page is not a buy recommendation. What the data shows today: bullish technical bias, RSI 47, price above its 50-day average and an estimated 51% probability of being higher in 1 month. Use it as a starting point for research, not as a signal.
🧠 How it is calculated
The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.
🔦 Keep analyzing
Other stocks Faro watches